The potential role of purinergic signaling in cancer therapy: perspectives on anti-CD73 strategies for prostate cancer

dc.contributor.author	Laufer, Stefan
dc.contributor.author	Morrone, Fernanda Bueno
dc.date.accessioned	2025-06-17T06:29:05Z
dc.date.available	2025-06-17T06:29:05Z
dc.date.issued	2024
dc.identifier.issn	1664-3224
dc.identifier.uri	http://hdl.handle.net/10900/166780
dc.language.iso	en	de_DE
dc.publisher	Lausanne : Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fimmu.2024.1455469	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	The potential role of purinergic signaling in cancer therapy: perspectives on anti-CD73 strategies for prostate cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250203000000_01294
utue.personen.roh	Gardani, Carla Fernanda Furtado
utue.personen.roh	Diz, Fernando Mendonca
utue.personen.roh	Donde, Luisa Brandalise
utue.personen.roh	Rockenbach, Liliana
utue.personen.roh	Laufer, Stefan
utue.personen.roh	Morrone, Fernanda Bueno
dcterms.isPartOf.ZSTitelID	Frontiers in Immunology	de_DE
dcterms.isPartOf.ZS-Issue	Article 1455469	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE